Filters Applied:
President Xi Jinping of China is buying time for Beijing and may see an opening with a U.S. president weakened by the war in Iran.
| Keywords | xi-jinpingtrumpchinaustaiwaniranwargeopoliticsworld-newsglobal-politicssecuritystrategic-uncertaintydefenseforeign-policywhite-houseus-politicsasiamiddle-eastiran-warred-green-axis |
Vice President JD Vance said the state had not done enough to fight fraud in the public health insurance program.
Also, Kevin Warsh is confirmed as the next Fed chair. Here’s the latest at the end of Wednesday.
A coalition of 29 major health care players is coming together to simplify the prior authorization process for medical treatments, Mehmet Oz , the administrator of the Centers for Medicare and Medicaid Services, said at Axios' Future of Health Summit Wednesday. The big picture: Last summer, several top health insurers voluntary pledged to streamline and improve the prior authorization process across all health insurance markets. Driving the news: "The payers, the insurance companies, have been playing ball. Guess who's not been playing ball until today? The providers," Oz told Axios' Caitlin Owens. - The new coalition includes insurers, hospitals and health records companies to streamline the process for reviewing medical procedures,…
“I don’t think about Americans’ financial situation,” he said of his calculations on the Iran war.
Sen. Peter Welch (D-Vt.) said Wednesday he'd back President Trump's push to pursue a "most-favored nation " drug policy at Wednesday's Axios Future of Health summit. Why it matters: Bipartisan support will be necessary for Congress to codify Trump's plan into law at a time when a majority of Americans are at least somewhat worried about being able to afford prescription drugs. - Trump's proposal would bring America's drug prices more in line with what other developed nations pay. What they're saying: Asked by Axios' Peter Sullivan if he'd vote for Trump's plan, Welch said he would "not only vote for it, I would work actively and aggressively to make it happen." - He noted that Trump hasn't introduced any legislation yet and he'd like…
Kouri Richins, 36, who wrote a children’s book about grief after murdering Eric Richins, will serve without the option of parole.
| Keywords | kouri-richinseric-richinsutahmurderpoisoningchildrens-book-authorprisonlife-sentencejusticelegal-newscriminal-casecourtroom-dramaus-justicebreaking-newscrimegriefjudicial-system |
Gov. Brian Kemp, a Republican, also asked lawmakers to delay changes to the state’s election system that could cause disarray in the midterms.
| Keywords | georgiabrian-kemprepublicanredistrictingelectionsspecial-session2028-electionstate-politicsmidtermsvotinggovernmentuslawmakers |
The New York Islanders defenseman was named the winner of the Calder Trophy, awarded to the NHL’s rookie of the year.
| Keywords | nhlmatthew-schaefernew-york-islanderscalder-trophyhockeynhl-rookiesports-newsdefensemanice-hockeyabc-newsathleteaward-winnersports-highlights |
The CEO of the main pharmaceutical company trade group on Wednesday called for the next Food and Drug Administration commissioner to "calm the waters" and ensure stability as drug companies develop new treatments. Why it matters: The FDA has faced a tumultous several months leading up to Commissioner Marty Makary's resignation Tuesday, with staff layoffs and top leaders heading out the door. What they're saying: "What we really need from the next leader of the FDA is to calm the waters and reestablish that certainty and predictability," PhRMA CEO Steve Ubl said at Axios' Future of Health Summit. - Bristol Myers Squibb CEO Chris Boerner sounded a similar theme, pointing to the years of work that go into developing a drug. - "What we need…